NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 21 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $58,000 | +13.7% | 105,975 | +21.8% | 0.03% | +13.8% |
Q2 2016 | $51,000 | -63.3% | 87,000 | -8.4% | 0.03% | -67.8% |
Q1 2016 | $139,000 | -51.7% | 95,000 | +5.6% | 0.09% | -39.6% |
Q4 2015 | $288,000 | -75.8% | 90,000 | -52.7% | 0.15% | -71.6% |
Q3 2015 | $1,188,000 | -29.2% | 190,141 | +12.5% | 0.52% | -24.3% |
Q2 2015 | $1,679,000 | +174.8% | 169,071 | +104.0% | 0.69% | +145.4% |
Q1 2015 | $611,000 | +70.7% | 82,875 | +23.9% | 0.28% | +74.1% |
Q4 2014 | $358,000 | +8.2% | 66,875 | +1.5% | 0.16% | +7.3% |
Q3 2014 | $331,000 | +17.8% | 65,875 | +57.3% | 0.15% | +10.2% |
Q2 2014 | $281,000 | +37.7% | 41,875 | +48.9% | 0.14% | +29.2% |
Q1 2014 | $204,000 | +104.0% | 28,125 | +5.8% | 0.11% | +82.8% |
Q4 2013 | $100,000 | +143.9% | 26,580 | +115.6% | 0.06% | +114.8% |
Q3 2013 | $41,000 | 0.0% | 12,330 | 0.0% | 0.03% | +8.0% |
Q2 2013 | $41,000 | – | 12,330 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Woodford Investment Management Ltd | 25,915,937 | $14,062,000 | 0.57% |
Family Management Corp | 105,975 | $58,000 | 0.03% |
HYMAN CHARLES D | 249,625 | $135,000 | 0.02% |
Montecito Bank & Trust | 75,717 | $41,000 | 0.02% |
WEDBUSH SECURITIES INC | 162,200 | $88,000 | 0.01% |
Cutler Group LLC / CA | 9,600 | $105,000 | 0.01% |
WHALEROCK POINT PARTNERS, LLC | 15,000 | $8,000 | 0.00% |
TELEMUS CAPITAL, LLC | 32,401 | $18,000 | 0.00% |
Hartford Financial Management Inc. | 4,000 | $2,000 | 0.00% |
GSA CAPITAL PARTNERS LLP | 40,825 | $22,000 | 0.00% |